Skip to content
Riskpilot
← Back to search
Sign in
Get full access
AB BBB Pharma
AB
Active
Org 5592144645
Skräddargårdshöjd 25, 517 37
Bollebygd
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2019 · 6 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
AB BBB Pharma
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
7M
15M
22M
30M
0M
2020
0M
2021
26M
2022
0M
2023
0M
2024
EBITDA
SEK millions
18M
13M
9M
4M
0M
0M
2020
0M
0%
2021
14M
+1400%
2022
0M
-100%
2023
0M
0%
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
—
0
26 278
—
0
Staff expenses
—
—
—
—
—
EBITDA
0
—
14 000
0
—
Depreciation & amort.
—
−0
−0
—
−0
EBIT
0
0
14 000
0
0
Net financials
—
3
—
—
−4
Profit before tax
0
4
14 000
0
−1
Tax
—
−0
−0
—
−11
Net profit
—
4
14 000
—
−12
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
—
53
61 858
—
105
Equity
—
53
61 858
—
105
Long-term debt
—
0
0
—
0
Short-term debt
—
0
0
—
0
Total debt
—
—
—
—
—
Financial ratios
5-year trend
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
2020
2024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
2020
2024
Return on equity
-11.4%
This company
18.4%
Market median
-162% vs market
2020
2024
Net profit margin
-1200000.0%
This company
8.1%
Market median
-14814915% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2019-08-01 – 2020-12-31
View
PDF
More on AB BBB Pharma
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
